Aprea Therapeutics, Inc. (APRE)

0.9381 +0.13 (+16.51%) USD  |  NASDAQ  |  Aug 25, 16:00
0.9702 +0.03 (+3.42%) After-Hours: 18:25
More

Aprea Therapeutics Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for APRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Quarter Chart
Start Trial

Historical Revenue Estimates for Current Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 13, 2026 --
August 12, 2026 --
August 10, 2026 --
June 01, 2026 --
May 15, 2026 --
May 13, 2026 --
May 07, 2026 --
April 06, 2026 --
March 31, 2026 --
March 16, 2026 --
February 09, 2026 --
December 31, 2025 --
Date Value
December 22, 2025 --
December 18, 2025 --
November 12, 2025 --
August 12, 2025 --
May 14, 2025 --
December 31, 2024 --
November 07, 2024 --
September 30, 2024 --
August 12, 2024 --
May 15, 2024 --
May 14, 2024 --

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Zymeworks, Inc. Upgrade
Rhythm Pharmaceuticals, Inc. Upgrade
Onconetix, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade

Revenue Estimates for Current Quarter Related Metrics

Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade